Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Current Pharmaceutical Design|May 18, 2012
Interleukin-6/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancerEveline M Dijkgraaf, Marij J P Welters, Johan W R Nortier, et al.International Journal of STD & AIDS|October 25, 2002
Financial situation of people living with HIV in EuropeW Schrooten, C Dreezen, J Borleffs, et al.The Journal of Laboratory and Clinical Medicine|April 25, 2000
Influence of ovariectomy on extracellular fluid volume in rats: assessment of extracellular fluid volume by means of bromideM Dijkgraaf-ten Bolscher, R Barto, D A Voorn, et al.JAMA Ophthalmology|March 15, 2014
Effect of hypoxic stress on migration and characteristics of monocytes in uveal melanomaInge H G Bronkhorst, Tina M L Jehs, Eveline M Dijkgraaf, et al.Cancer Research|February 26, 2013
Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironmentEveline M Dijkgraaf, Moniek Heusinkveld, Bart Tummers, et al.Oncoimmunology|May 13, 2015
Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancerMcA Wouters, E M Dijkgraaf, M L Kuijjer, et al.Oncoimmunology|September 18, 2018
The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survivalS J A M Santegoets, A F de Groot, E M Dijkgraaf, et al.BMC Neurology|November 21, 2015
Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-studyConstant V M Verschuur, S R Suwijn, B Post, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancerE M Dijkgraaf, S J A M Santegoets, A K L Reyners, et al.Cancer Immunology, Immunotherapy : CII|July 1, 2015
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometrySaskia J A M Santegoets, Eveline M Dijkgraaf, Alessandra Battaglia, et al.Pageof 3